These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 33694084)

  • 1. Admission lysophosphatidylethanolamine acyltransferase level predicts the severity and prognosis of community-acquired pneumonia.
    Chen L; Zhao L; Shang Y; Xu Y; Gao Z
    Infection; 2021 Oct; 49(5):877-888. PubMed ID: 33694084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine acyltransferase level predicts the severity and prognosis of patients with community-acquired pneumonia: a prospective multicenter study.
    Chen L; Xue J; Zhao L; He Y; Fu S; Ma X; Yu W; Tang Y; Wang Y; Gao Z
    Front Immunol; 2023; 14():1295353. PubMed ID: 38259459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of Lysophosphatidylcholine for Determining the Disease Severity and Prognosis of Elderly Patients with Community-Acquired Pneumonia.
    Gu M; Lv S; Song Y; Wang H; Zhang X; Liu J; Liu D; Han X; Liu X
    Clin Interv Aging; 2024; 19():517-527. PubMed ID: 38528884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Serum S100A12 With Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Prospective Cohort Study.
    Jiang X; Huang CM; Feng CM; Xu Z; Fu L; Wang XM
    Front Immunol; 2021; 12():714026. PubMed ID: 34745092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of risk scores in predicting mortality at 3, 6, and 12 months in patients diagnosed with community-acquired pneumonia.
    Tuta-Quintero E; Bastidas AR; Guerrón-Gómez G; Perna-Reyes I; Torres D; Garcia L; Villanueva J; Acuña C; Mikler E; Arcila J; Chavez N; Riviera A; Maldonado V; Galindo M; Fernández M; Schloss C; Reyes LF
    BMC Pulm Med; 2024 Jul; 24(1):334. PubMed ID: 38987754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of daily living upon admission is an independent predictor of in-hospital mortality in older patients with community-acquired pneumonia.
    Kang Y; Fang XY; Wang D; Wang XJ
    BMC Infect Dis; 2021 Apr; 21(1):314. PubMed ID: 33794779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CURB-65 scoring system in severity assessment of Eastern Nigerian patients with community-acquired pneumonia: a prospective observational study.
    Mbata GC; Chukwuka CJ; Onyedum CC; Onwubere BJ
    Prim Care Respir J; 2013 Jun; 22(2):175-80. PubMed ID: 23633130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IL-27 predicts the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
    Xu Z; Wang XM; Cao P; Zhang C; Feng CM; Zheng L; Xu DX; Fu L; Zhao H
    Int J Med Sci; 2022; 19(1):74-81. PubMed ID: 34975300
    [No Abstract]   [Full Text] [Related]  

  • 9. Machine learning-based derivation and validation of three immune phenotypes for risk stratification and prognosis in community-acquired pneumonia: a retrospective cohort study.
    Qin Q; Yu H; Zhao J; Xu X; Li Q; Gu W; Guo X
    Front Immunol; 2024; 15():1441838. PubMed ID: 39114653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive and Prognostic Utility of the Serum Level of Resistin-Like Molecule Beta for Risk Stratification in Patients with Community-Acquired Pneumonia.
    Chen L; Luo Q; Shang Y; He X; Xu Y; Gao Z
    Pathogens; 2021 Jan; 10(2):. PubMed ID: 33503890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the pneumonia severity index. Importance of study-specific recalibration.
    Flanders WD; Tucker G; Krishnadasan A; Martin D; Honig E; McClellan WM
    J Gen Intern Med; 1999 Jun; 14(6):333-40. PubMed ID: 10354252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia.
    Müller-Plathe M; Osmanodja B; Barthel G; Budde K; Eckardt KU; Kolditz M; Witzenrath M
    Infection; 2024 Apr; 52(2):447-459. PubMed ID: 37985643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of malnutrition for long-term mortality in community-acquired pneumonia: a propensity score matched analysis.
    Yeo HJ; Byun KS; Han J; Kim JH; Lee SE; Yoon SH; Jeon D; Kim YS; Cho WH
    Korean J Intern Med; 2019 Jul; 34(4):841-849. PubMed ID: 30685962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma proteome analysis and validation of patients with community-acquired pneumonia: A cohort study.
    Zhao L; Bian W; Shang Y; Zhi H; Ma X; He Y; Yu W; Liu C; Xu Y; Gong P; Gao Z
    Proteomics Clin Appl; 2024 Jul; 18(4):e202300069. PubMed ID: 38332320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive comparison of clinicoradiological, laboratory, and prognostic factors of community-acquired pneumonia in diabetic and nondiabetic hospitalized patients.
    Hashemi SH; Saki F; Borzouei S; Bawand R; Soltanian A
    Turk J Med Sci; 2023; 53(6):1776-1785. PubMed ID: 38813518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of NEWS2 and PSI as mortality predictors in patients with community acquired pneumonia.
    Kumari N; Saifullah N; Jafri S; Ahmed A; Jawad N; Ahmed N
    J Pak Med Assoc; 2024 Jun; 74(6):1156-1159. PubMed ID: 38948989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and external validation of a scoring prediction model for mortality risk within 30 days of community-acquired pneumonia in children admitted to the pediatric intensive care unit: A multicenter retrospective case-control study.
    Cheng X; Wang H; Sun L; Ge W; Liu R; Qin H; Zhang Y; Li C
    Medicine (Baltimore); 2024 Mar; 103(10):e37419. PubMed ID: 38457576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival at 3, 6 and 12 months in patients diagnosed with community-acquired pneumonia in Colombia: a retrospective cohort study.
    Tuta-Quintero E; Torres-Arevalo D; Bastidas-Goyes AR; Aponte-Murcia HC; Guerrero M; Giraldo A; Villarraga L; Orjuela L; Hernández J; Giraldo-Cadavid LF
    Braz J Infect Dis; 2024; 28(4):103852. PubMed ID: 39043283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-486-5p predicted adverse outcomes of SCAP and regulated K. pneumonia infection via FOXO1.
    Jin Q; Liu C; Cao Y; Wang F
    BMC Immunol; 2024 Jun; 25(1):33. PubMed ID: 38834979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum activin A as a prognostic biomarker for community acquired pneumonia.
    Wang YT; Liu Y; Zhou GH; Liu K; Fen Y; Ding H
    World J Clin Cases; 2024 Aug; 12(22):5016-5023. PubMed ID: 39109010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.